p53 and proliferating cell nuclear antigen in endocrine tumors of pancreas and intestinal carcinoids

Pathology

Volumn 29, Issue 2, 1997, Pages 147-153

  Tomita, Tatsuo ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Carcinoids; Immunocytochemistry; p53; Pancreatic endocrine tumors; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; PROTEIN P53;

ADULT; AGED; APPENDIX CANCER; ARTICLE; CARCINOID; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; GASTRINOMA; GLUCAGONOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INSULINOMA; INTESTINE CARCINOMA; MALE; PANCREAS ISLET CELL; PANCREAS TUMOR;

EID: 0030798079     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029700169774     Document Type: Article

References (14)

1. Montenarh M. Biochemical properties of the growth suppressor/oncoprotein p53. Oncogene 1992; 7: 1673-80.
2. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991; 253: 49-53.
3. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, Kovarik J, Midgley CA, Gannon JV, Lane DP. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991; 6: 1699-703.
4. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol 1992; 140: 145-53.
5. van den Berg FM, Tigges AJ, Schipper ME, Den Hartog-Jager FC, Kroes WG, Walboomers JM. Expression of the nuclear oncogene p53 in colon tumours. J Pathol 1989; 157: 193-9.
6. Purdie CA, O'Grady J, Piris J, Wyllie AH, Bird CC. p53 expression in colorectal tumors. Am J Pathol1992; 138: 807-13.
7. Shirasawa S, Ubabe K, Yanagawa Y, Toshitani K, Iwama T, Sasazuki T. p53 gene mutation in colorectal tumors from patients with familial polyposis. Cancer Res 1991; 51: 2874-8.
8. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53 mutation in colorectal cancer. Proc Natl Acad Sci USA 1990; 87: 7555-9.
9. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Wilson JK, Hamilton S, Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990; 50: 7717-22.
10. Walker RA, Dealing SJ, Lane DP, Varley JM. Expression of p53 protein in infiltrating and in-situ breast carcinomas. J Pathol 1991; 165: 203-11.
11. Bodner SM, Minna JD, Jensen SM, D'Araico D, Carbone D, Mitsudomi T, Fedorko J, Buchhagen DL, Nau MM, Gazdar Linnoila I. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 1992; 7: 743-9.
12. Sameshima Y, Matsuno Y, Horohashi S, Shimosato Y, Mizoguchi H, Sugimura T, Terada M, Yokota J. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene 1991; 7: 451-7.
13. Nuorva K, Soini Y, Kamel D, Autio-Harmainen H, Risteli L, Risteli J, Vahakangas K, Paakko P. Concurrent p53 expression in bronchial dysplasia and squamous cell lung carcinomas. Am J Pathol 1993; 142: 725-32.
14. Holm R, Skomedal H, Heiland A, Kristensen G, Borrensen A-L, Nesland JM. Immunohistochemical analysis of p53 protein overexpression in normal, pre-malignant and malignant tissues of the cervix uteri. J Pathol 1993; 169: 21-6.